Expression and function of ErbB receptors and ligands in the pituitary

被引:54
作者
Cooper, Odelia [1 ]
Vlotides, George [2 ]
Fukuoka, Hidenori [1 ]
Greene, Mark I. [3 ,4 ]
Melmed, Shlomo [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA
[2] Univ Munich, Dept Med 2, Univ Hosp Munich Grosshadern, Munich, Germany
[3] Cedars Sinai Med Ctr, Dept Biomed Sci & Pathol & Lab Med, Los Angeles, CA 90048 USA
[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
EPIDERMAL-GROWTH-FACTOR; GONADOTROPIN-RELEASING-HORMONE; RAT ANTERIOR-PITUITARY; FACTOR-BINDING-SITES; FACTOR-ALPHA; LUTEINIZING-HORMONE; REPRODUCTIVE FUNCTION; GENE-EXPRESSION; MESSENGER-RNA; GH4C1; CELLS;
D O I
10.1530/ERC-11-0066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of ErbB family in discreet pituitary functions is reviewed. Several ErbB receptor ligands, EGF, TGF alpha, and heregulin are differentially expressed in normal gonadotroph and lactosomatotroph lineages, and other elements of the anterior pituitary. ErbB receptors, i.e. EGFR and ErbB2, are also localized to the anterior pituitary with preferential EGFR lactosomatotroph expression. EGF regulates CRH and ACTH secretion and corticotroph proliferation as well as exhibiting autocrine and paracrine effects on gonadotrophs and on lactosomatotroph proliferation, gene and protein expression, and hormonal secretion. EGF and EGFR are expressed in both functioning and non-functioning pituitary adenomas, with higher expression in more aggressive tumor subtypes. ErbB2 receptor is detected in all tumor subtypes, particularly in invasive tumors. ErbB tyrosine kinase inhibitors regulate hormonal secretion, cell morphology, and proliferation in lacto-somatotroph tumors, reflecting the emerging application of targeted pituitary therapeutics. Endocrine-Related Cancer (2011) 18 R197-R211
引用
收藏
页码:R197 / R211
页数:15
相关论文
共 95 条
  • [1] EPIDERMAL GROWTH-FACTOR STIMULATES THE PROLACTIN SYNTHESIS AND SECRETION IN RAT PITUITARY-CELLS IN CULTURE (GH4C1 CELLS) BY INCREASING THE INTRACELLULAR CONCENTRATION OF FREE CALCIUM
    AANESTAD, M
    ROTNES, JS
    TORJESEN, PA
    HAUG, E
    SAND, O
    BJORO, T
    [J]. ACTA ENDOCRINOLOGICA, 1993, 128 (04): : 361 - 366
  • [2] Changes in expression of epidermal growth factor receptors by anterior pituitary galls during the estrous cycle: Cyclic expression by gonadotropes
    Armstrong, J
    Childs, GV
    [J]. ENDOCRINOLOGY, 1997, 138 (05) : 1903 - 1908
  • [3] Regulation of expression of epidermal growth factor receptors in gonadotropes by epidermal growth factor and estradiol: Studies in cycling female rats
    Armstrong, JL
    Childs, GV
    [J]. ENDOCRINOLOGY, 1997, 138 (12) : 5434 - 5441
  • [4] Estrogen Receptor-α Mediates the Epidermal Growth Factor-Stimulated Prolactin Expression and Release in Lactotrophs
    Ben-Jonathan, Nira
    Chen, Shenglin
    Dunckley, Joseph A.
    LaPensee, Christopher
    Kansra, Sanjay
    [J]. ENDOCRINOLOGY, 2009, 150 (02) : 795 - 802
  • [5] THYROTROPIN-RELEASING-HORMONE AND EPIDERMAL GROWTH-FACTOR INDUCE HUMAN PROLACTIN EXPRESSION VIA IDENTICAL MULTIPLE CIS ELEMENTS
    BERWAER, M
    PEERS, B
    NALDA, AM
    MONGET, P
    DAVIS, JRE
    BELAYEW, A
    MARTIAL, JA
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1993, 92 (01) : 1 - 7
  • [6] EPIDERMAL GROWTH FACTOR-BINDING SITES, PRESENT IN NORMAL HUMAN AND RAT PITUITARIES, ARE ABSENT IN HUMAN PITUITARY-ADENOMAS
    BIRMAN, P
    MICHARD, M
    LI, JY
    PEILLON, F
    BRESSION, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (02) : 275 - 281
  • [7] Expression of p53, Ki-67 and c-erb B2 in growth hormone- and/or prolactin-secreting pituitary adenomas
    Botelho, CHA
    de Magalhaes, AVD
    de Mello, PA
    Schmitt, FC
    Casulari, LA
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2006, 64 (01) : 60 - 66
  • [8] Role of heregulin in human cancer
    Breuleux, M.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (18) : 2358 - 2377
  • [9] BROCKES JP, 1980, J BIOL CHEM, V255, P8374
  • [10] BROWN BW, 1989, J REPROD FERTIL, V87, P649, DOI 10.1530/jrf.0.0870649